Cargando…
Antibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus
BACKGROUND: Zika virus (ZIKV) infection is a global health problem, and its complications, including congenital Zika syndrome and Guillain-Barré syndrome, constitute a continued threat to humans. Unfortunately, effective therapeutics against ZIKV infection are not available thus far. METHODS: We scr...
Autores principales: | Yuan, Jie, Yu, Jianchen, Huang, Yun, He, Zhenjian, Luo, Jia, Wu, Yun, Zheng, Yingchun, Wu, Jueheng, Zhu, Xun, Wang, Haihe, Li, Mengfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392643/ https://www.ncbi.nlm.nih.gov/pubmed/32731873 http://dx.doi.org/10.1186/s12916-020-01663-1 |
Ejemplares similares
-
RdRp or RT, That is the Question
por: Peyambari, Mahtab, et al.
Publicado: (2021) -
Snapshots of a Non-Canonical RdRP in Action
por: Ferrero, Diego S., et al.
Publicado: (2021) -
Aging correlates with lower threshold cycle values for RdRP/RdRP+S genes during molecular detection of SARS-CoV-2
por: Mikuła-Pietrasik, Justyna, et al.
Publicado: (2021) -
In silico investigation to identify potential small molecule inhibitors of the RNA-dependent RNA polymerase (RdRp) nidovirus RdRp-associated nucleotidyltransferase domain
por: Pitsillou, Eleni, et al.
Publicado: (2021) -
Inhibition of HEV Replication by FDA-Approved RdRp
Inhibitors
por: Hooda, Preeti, et al.
Publicado: (2023)